KR101034986B1 - Composition comprising the mixed herbal extract for relieving hangover - Google Patents
Composition comprising the mixed herbal extract for relieving hangover Download PDFInfo
- Publication number
- KR101034986B1 KR101034986B1 KR1020100130184A KR20100130184A KR101034986B1 KR 101034986 B1 KR101034986 B1 KR 101034986B1 KR 1020100130184 A KR1020100130184 A KR 1020100130184A KR 20100130184 A KR20100130184 A KR 20100130184A KR 101034986 B1 KR101034986 B1 KR 101034986B1
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- extract
- hangover
- turmeric
- weight
- Prior art date
Links
- 206010019133 Hangover Diseases 0.000 title claims abstract description 48
- 239000000203 mixture Substances 0.000 title abstract description 77
- 239000012676 herbal extract Substances 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 88
- 239000000284 extract Substances 0.000 claims abstract description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 238000001035 drying Methods 0.000 claims abstract description 7
- 238000001914 filtration Methods 0.000 claims abstract description 7
- 239000012141 concentrate Substances 0.000 claims abstract description 4
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 34
- 235000003373 curcuma longa Nutrition 0.000 claims description 34
- 235000013976 turmeric Nutrition 0.000 claims description 34
- 244000008991 Curcuma longa Species 0.000 claims description 33
- 241000218201 Ranunculaceae Species 0.000 claims description 17
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 235000011197 perejil Nutrition 0.000 claims description 10
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 230000036541 health Effects 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 5
- 235000013376 functional food Nutrition 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 240000009164 Petroselinum crispum Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 24
- 108010021809 Alcohol dehydrogenase Proteins 0.000 abstract description 13
- 235000013402 health food Nutrition 0.000 abstract description 7
- 235000003398 Curcuma aromatica Nutrition 0.000 abstract description 3
- 240000008881 Oenanthe javanica Species 0.000 abstract description 3
- 235000000365 Oenanthe javanica Nutrition 0.000 abstract description 3
- 244000046146 Pueraria lobata Species 0.000 abstract description 3
- 235000010575 Pueraria lobata Nutrition 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 244000164480 Curcuma aromatica Species 0.000 abstract 2
- 230000000052 comparative effect Effects 0.000 description 42
- 238000002360 preparation method Methods 0.000 description 15
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 12
- 206010019233 Headaches Diseases 0.000 description 10
- 241000218206 Ranunculus Species 0.000 description 10
- 235000013361 beverage Nutrition 0.000 description 10
- 231100000869 headache Toxicity 0.000 description 10
- 241000208317 Petroselinum Species 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 230000035922 thirst Effects 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 230000004060 metabolic process Effects 0.000 description 7
- 241000700159 Rattus Species 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 5
- 239000003651 drinking water Substances 0.000 description 5
- 235000020188 drinking water Nutrition 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 4
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 244000163122 Curcuma domestica Species 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 235000020240 turmeric extract Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241001107116 Castanospermum australe Species 0.000 description 2
- 108010001202 Cytochrome P-450 CYP2E1 Proteins 0.000 description 2
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 2
- 102000003849 Cytochrome P450 Human genes 0.000 description 2
- 102100024889 Cytochrome P450 2E1 Human genes 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 240000001417 Vigna umbellata Species 0.000 description 2
- 235000011453 Vigna umbellata Nutrition 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 235000021279 black bean Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000002489 hematologic effect Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229940041476 lactose 100 mg Drugs 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 239000006193 liquid solution Substances 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- -1 olive oil Chemical compound 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 239000008513 turmeric extract Substances 0.000 description 2
- 229940052016 turmeric extract Drugs 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010001605 Alcohol poisoning Diseases 0.000 description 1
- 235000013479 Amaranthus retroflexus Nutrition 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000219495 Betulaceae Species 0.000 description 1
- 206010048909 Boredom Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 240000005674 Ceanothus americanus Species 0.000 description 1
- 235000014224 Ceanothus americanus Nutrition 0.000 description 1
- 235000001904 Ceanothus herbaceus Nutrition 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 102000009645 Mitochondrial Aldehyde Dehydrogenase Human genes 0.000 description 1
- 108010009513 Mitochondrial Aldehyde Dehydrogenase Proteins 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- 206010030216 Oesophagitis Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 239000009262 Puerariae Radix plant extract Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 244000019194 Sorbus aucuparia Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229940037769 calcium carbonate 100 mg Drugs 0.000 description 1
- 229940043430 calcium compound Drugs 0.000 description 1
- 150000001674 calcium compounds Chemical class 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 244000013123 dwarf bean Species 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 208000006881 esophagitis Diseases 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 239000004083 gastrointestinal agent Substances 0.000 description 1
- 229940127227 gastrointestinal drug Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 210000001853 liver microsome Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 230000004066 metabolic change Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 231100000668 minimum lethal dose Toxicity 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 230000005813 organ abnormality Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229930195353 puerin Natural products 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 235000006414 serbal de cazadores Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000018316 severe headache Diseases 0.000 description 1
- 210000000323 shoulder joint Anatomy 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 235000019997 soju Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 210000001321 subclavian vein Anatomy 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940033203 vitamin b6 0.5 mg Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Abstract
Description
본 발명은 숙취해소용 조성물에 관한 것으로서, 미나리, 갈근 및 강황을 함유하는 숙취해소용 조성물 및 건강기능식품에 관한 것이다.The present invention relates to a hangover relief composition, and to a hangover relief composition and health functional food containing buttercups, brown root and turmeric.
대사(metabolism, 代謝)란 정상으로 섭취된 물질을 다른 화합물(metabolites, 대사물질)로 변화시켜 주는 생체의 한 화학 반응이다. 우리가 영양분으로 사용하고 있는 음식물의 소화, 분해는 물론이고, 필요에 따라 3대 영양분(탄수화물, 단백질, 지방)의 구성성분 간의 상호 변화도 대사 작용에 포함된다. 외부에서 들어오는 물질의 경우, 대사 후에 원래보다 더욱 독성이 강한 대사산물이 간혹 생성되어 신체 조직에 해를 입힐 때도 있다. 술(알코올)의 경우는 물에 잘 녹아 음주 후에는 위장관에서 흡수되어 혈류를 통해 뇌와 간을 포함한 신체 각 조직에 분포된다. 혈류를 통해 간에 운반된 알코올은 알코올 탈수소효소(Alcohol dehydrogenase, ADH)라는 효소에 의해 산화되어 아세트알데히드(acetaldehyde)가 되고, 또 알데히드 탈수소효소(Aldehyde dehydrogenase, ALDH)에 의해 다시 산화되어 아세트산으로 변한다. 이 두 가지 효소의 경우 NAD라는 조효소를 사용하는데, NADH와 H+ 를 생성한다. 아세트산으로 변한 알코올은 각 조직에 운반되어 산화(대사)되고 아세틸 CoA를 거쳐 이산화탄소(CO2)와 물(H2O)로 변한다. 일부(약 20% 정도)의 술은 간의 마이크로솜(소포체) 만이 존재하는 알코올 유발성 사이토크롬 P450(CYP2E1)에 의한 효소에 의해 대사를 받아 아세트알데히드를 거쳐 아세트산으로 대사되기도 한다. 간에서 대사 받지 않은 알코올은 혈중에 남아 있다가 숨(호흡기), 피부 또는 뇨(Urine)로 배출된다. 알코올은 섭취량이나 혈중농도에 관계없이 매시간당 일정량만 대사된다. 각 사람의 간에 주로 존재하는 알코올 탈수소효소, 알데히드 탈수소효소 및 알코올유도성 사이토크롬 P450(CYP2E1)의 양에 의존하여 대사된다. 이들 효소들의 역가나 농도는 각 개인의 유전적인 정보나 환경적인 요인에 의하여 결정되는데 각 개인의 성별, 연령, 체중, 영양상태 및 신체 조건에 따라 어느 정도 영향을 받기도 한다.Metabolism is a chemical reaction in living organisms that converts normally ingested substances into other compounds (metabolites). In addition to digesting and breaking down the foods we use as nutrients, we also include metabolic changes between components of the three major nutrients (carbohydrates, proteins and fats) as needed. In the case of substances coming from outside, metabolites that are more toxic than the original are sometimes produced after metabolism, causing harm to body tissues. Alcohol (alcohol) is well dissolved in water, after drinking it is absorbed by the gastrointestinal tract and distributed through the bloodstream to the tissues of the body, including the brain and liver. Alcohol transported to the liver through the bloodstream is oxidized by an enzyme called alcohol dehydrogenase (ADH) to be acetaldehyde, and then oxidized by aldehyde dehydrogenase (ALDH) to acetic acid. Both of these enzymes use a coenzyme called NAD, which produces NADH and H +. Alcohol converted to acetic acid is transported to each tissue, oxidized (metabolized) and converted to carbon dioxide (CO 2 ) and water (H 2 O) via acetyl CoA. Some (about 20%) alcohol is metabolized by an alcohol-induced cytochrome P450 (CYP2E1) enzyme in which only the liver microsomes (vesicles) are present, and then metabolized to acetic acid via acetaldehyde. Alcohol that is not metabolized in the liver remains in the blood and is released into the breath (breath), skin, or urine (Urine). Alcohol is only metabolized every hour, regardless of intake or blood levels. It is metabolized depending on the amount of alcohol dehydrogenase, aldehyde dehydrogenase, and alcohol-induced cytochrome P450 (CYP2E1), which are mainly present in each human liver. The titer or concentration of these enzymes is determined by genetic information or environmental factors of the individual, which may be affected in some ways by the individual's gender, age, weight, nutritional status and physical condition.
일예로, 젊고 건장한 남성이 나이가 많은 남자나 여자보다 훨씬 더 빨리 알코올을 대사시킬 수 있다. 실제로 같은 양의 알코올을 남녀가 마셨을 경우 여자의 혈중 알코올농도(Blood Alcohol Concentration, BAC)가 높아 여자들이 남자보다 간, 뇌 또는 심장에 조직손상을 많이 입는다고 보고되어 있다. 이 경우 여자들의 평균 체중이 남자보다 적어 간의 알코올 효소량 및 몸의 수분 함량이 적기 때문에 알코올 분포시 남자보다 상대적으로 알코올 혈중 농도가 높아진다.For example, young and strong men can metabolize alcohol much faster than older men and women. In fact, women who drink the same amount of alcohol have a higher blood alcohol concentration (BAC) in women, which is reported to cause more tissue damage to the liver, brain or heart than men. In this case, the average body weight of women is lower than that of men, because the amount of alcohol enzymes in the liver and the water content of the body is less, so the alcohol blood concentration is higher than the alcohol distribution.
한국인을 포함한 일부 동양인들(중국, 일본인을 포함하여 약 20~40%)에게는 ADH나 ALDH 효소에 유전적으로 다른 돌연변이가 존재한다. 특히 아세트알데히드의 대사에 관여하는 ALDH2 효소 중 글루타민산이 라이신이라는 아미노산으로 돌연변이가 되어 이 효소의 역가가 현저히 감소한다. 이들은 술을 한잔만 해도 아세트알데히드가 축적되어 얼굴이 홍시처럼 붉어지는 홍조증을 나타낸다. 이런 사람들의 경우, 주위의 강압적인 분위기 때문에 알코올을 더 마시면 생체에 유독한 아세트알데히드가 축적되어 생체내의 고분자 단백질들과 반응하여, 그들 고유의 기능을 저하시키는 악영향을 미친다고 잘 알려져 있기 때문에 더욱 조심해야 한다.Some Asians, including Koreans (about 20-40%, including Chinese and Japanese), have genetically different mutations in ADH or ALDH enzymes. In particular, among the ALDH2 enzymes involved in acetaldehyde metabolism, glutamic acid is mutated to an amino acid called lysine, which significantly reduces the titer of this enzyme. They have flushing acetaldehyde even after a drink, causing the flushing to look red. These people are more cautious because they are known to drink more alcohol because of the coercive atmosphere of their surroundings, which accumulates toxic acetaldehyde in the living body and reacts with the polymer proteins in the living body, which adversely affects their own functions. Should be.
한편, 미나리(Oenanthe javanica)는 쌍떡잎식물 산형화목 미나리과의 여러해살이풀로 습지에서 자라고 논에 재배하는데 줄기의 마디에서 뿌리가 내려 번식한다. 미나리는 피를 맑게 해주며, 퀘르세틴과 캠프페롤이라는 항산화 물질 함량이 높아 체내에 활성산소 생성을 억제해 세포의 염증 유발을 감소시키는 효능뿐만 아니라 유방암, 대장암, 난소암, 위암 등을 예방하는 효과도 있다. 미나리는 해독작용이 뛰어나며, 혈압 강하작용이 있어 고혈압 환자에 좋고, 식이섬유를 많이 함유하고 있어 유해물질을 해독하며, 가래를 제거하는 효능이 있다. 또한, 비타민 A, B, C가 고루 함유되어 있으며, 특히 비타민 A가 많다. 이밖에 식욕을 돋우고 혈압을 낮추며 섬유질이 풍부해 식물성 섬유가 창자의 내벽을 자극하여 장운동을 촉진시켜 변비를 해소하는 작용을 한다.On the other hand, Oenanthe javanica is a perennial plant of the dicotyledon type Asteraceae, which grows in marshes and grows in paddy fields. Buttercup clears the blood and contains high amounts of antioxidants such as quercetin and camphorol, which inhibits the production of free radicals in the body, reducing the inflammation of the cells, as well as preventing breast cancer, colon cancer, ovarian cancer and stomach cancer. There is also. Buttercup is excellent detoxification, blood pressure lowering action is good for hypertensive patients, and contains a lot of dietary fiber detoxify harmful substances, has the effect of removing sputum. In addition, vitamins A, B, and C are evenly contained, especially vitamin A. In addition, it stimulates appetite, lowers blood pressure, and is rich in fiber, which stimulates the inner wall of the intestine to promote bowel movements, thereby relieving constipation.
갈근(Pueraria lobata (Willd.) Ohwi)은 콩과에 속한 다년생 낙엽등본식물인 칡의 뿌리를 말하며, 이소플라본 성분의 푸에라린, 베타-시토스테롤, 아락킨산과 다량의 전분이 함유되어 있다. 해열제로서 고열, 두통을 치료하고 진액을 생기게 하고 갈증을 멎게 하며, 병을 다스리기 위해 땀을 내게 할 때나 해열할 때 많이 쓰지만 다른 여러 증상에도 두루 사용된다. 또한, 소화불량, 두통, 빈혈, 이질, 복통, 술독, 감기 등에 쓰이고 민간에서는 위장약으로 사용한다.The root of Pueraria lobata (Willd.) Ohwi is the root of the perennial deciduous plant belonging to the legume, which contains puerin, beta-sitosterol, alacchinic acid and a lot of starch. As an antipyretic, it can be used to treat high fever, headaches, create essences, quench thirst, and sweat and cure fever, but it is also used for many other symptoms. In addition, it is used for indigestion, headache, anemia, dysentery, abdominal pain, alcohol poisoning, cold, etc., and is used as a gastrointestinal drug in the civilian.
강황(Curcuma aromatica)은 외떡잎식물 생강목 생강과의 한해살이풀로 봄울금이라고도 한다. 강황은 맵고 쓴맛이 있어 후추와 비슷한 향신료로 사용되며, 황금 주홍색을 띠기 때문에 음식을 노랗게 물들이는데도 사용된다. 노란색을 띠는 것은 커큐민이라는 색소 성분 때문인데 이는 활성산소를 파괴해 노화방지는 물론 치매 예방에도 효과가 있으며 치매에 걸린 환자들의 뇌 속에 쌓인 활성산소와 유해물질을 제거해 인지능력을 높이는 효능이 있다. 한방에서는 강황을 혈액순환장애 치료제로 사용하는데 어혈을 제거하고 혈액순환을 촉진하는 기능이 있기 때문이다. 이 밖에 생리통 완화, 어깨 관절통, 타박상, 고혈압의 치료에도 쓰인다. Curcuma aromatica is a perennial herb that is a monocotyledonous plant, Ginger neck, also known as spring turmeric. Turmeric has a spicy, bitter taste and is used as a pepper-like spice, and because of its golden scarlet color, it is also used to dye food yellow. The yellow color is due to a pigment called curcumin, which is effective in destroying free radicals to prevent aging and prevent dementia, and to increase cognitive abilities by removing free radicals and harmful substances accumulated in the brain of patients with dementia. In Chinese medicine, turmeric is used as a blood circulation disorder treatment because it removes fish blood and promotes blood circulation. In addition, it is used to relieve menstrual pain, shoulder joint pain, bruises, and high blood pressure.
따라서 상기와 같은 효능이 있는 미나리, 갈근 또는 강황을 함유하는 다양한 식품이 개발되어 있으며, 특히 한국공개특허 제2008-35853호에는 미나리의 열수 추출물 및 그 분획의 추출물을 유효성분으로 하는 숙취 해소용 조성물을 제조하고 이를 이용하여 기능성 건강식품을 제조함으로써 혈중 알코올 및 아세트알데히드 대사를 촉진시켜 숙취에 따른 생리학적 부작용을 경감시켜 숙취를 치료하거나 또는 예방하는 효과를 가지는 식품조성물, 한국공개특허 제2010-50032호에는 이온화칼슘 시비 현미에 흑두, 녹두, 갈근, 갈화, 미나리 등을 더 포함하여 추출한 알코올 배설과 아세트알데히드 대사촉진 및 숙취 해소능이 있는 조성물, 한국공개특허 제2010-26487호에는 대추, 울금(강황), 감초, 감국, 갈근 등을 열수추출하고 여과하여 고형분을 제거한 후 숙성하여 제조된 숙취해소음료, 한국등록특허 제514442호에는 헛개나무 열매, 갈근, 미나리, 호박 등의 혼합 추출액에 과당, 아스파라긴산, 타우린을 혼합하여 제조되어 이취가 없어 용이하게 음용할 수 있는 숙취해소 음료, 한국공개특허 제2009-78662호에는 칼슘 화합물을 주성분으로 하고 여기에 흑두, 녹두, 적소두, 지구자, 갈근, 감초, 오매 등을 알코올이나 열수를 용매로서 이용하여 추출하고, 상기 추출물에 설탕 또는 포도당과, 말레인산, 젖산 또는 그 염을 용해시킨 알코올 분해 촉진 및 숙취 해소에 있어서 우수한 효과를 갖는 숙취 해소용 조성물, 한국등록특허 제706465호에는 유산균 배양액과 강황분말을 혼합하고 이를 배양조에서 발효시켜 얻어진 결과물을 주성분으로 하고 여기에 숙취해소를 위한 부수적인 조성물들을 첨가하여 제조된 숙취 해소용 혼합음료, 한국등록특허 제181168호에는 오리나무추출물과 마가목추출물에 여정실추출물, 갈근추출물, 박추출물 등을 첨가하여 제조된 숙취해소용 천연차 등이 게시되어 있다.Therefore, various foods containing buttercups, brown roots or turmeric having the above effects have been developed, and in particular, Korean Laid-Open Patent Publication No. 2008-35853 discloses a hangover-relieving composition using the extract of hot water and extracts of the parsley as an active ingredient. Food composition having the effect of treating or preventing a hangover by promoting the metabolism of alcohol and acetaldehyde in blood to reduce the physiological side effects of the hangover by preparing a functional health food using the same, and Korean Patent Publication No. 2010-50032 No. Calcium ion fertilized brown rice, black bean, mung bean, brown root, browning, parsley, alcohol excretion and acetaldehyde metabolism and hangover resolving ability, Korea Patent Publication No. 2010-26487 jujube, turmeric ), Licorice, persimmon soup, brown root, etc., are extracted with hot water and filtered to remove solids. Manufactured hangover drink, Korean Registered Patent No. 514442 is prepared by mixing fructose, aspartic acid, taurine with a mixed extract of the bark fruit, brown root, buttercup, pumpkin, etc. Korean Patent Laid-Open Publication No. 2009-78662 discloses a calcium compound as a main ingredient, and extracts black bean, green bean, red bean bean, red bean, red root, licorice, ume, etc. using alcohol or hot water as a solvent, and extracts sugar or glucose. And hangover resolution composition having excellent effect in promoting alcohol decomposition and resolving hangover by dissolving maleic acid, lactic acid or salt thereof, Korean Patent No. 706465 is obtained by mixing a lactic acid bacteria culture medium and turmeric powder and fermenting them in a culture tank. Hangover horn prepared by using the resultant as a main ingredient and additional compositions for hangover elimination Drinks, Korea Patent No. 181168 discloses the alder extract and extract yeojeongsil Rowan extract, Puerariae Radix extract to a screeching prepared by adding the extract of watermelon plants, such as natural tea are posted.
그러나 상기와 같이, 미나리, 갈근 및 강황을 모두 함유하는 숙취해소용 조성물은 개발되어 있지 않은 실정이다.However, as described above, hangover relief composition containing both buttercups, brown root and turmeric has not been developed.
따라서, 본 발명자들은 숙취해소용 조성물에 대해 연구한 결과, 미나리, 갈근 및 강황을 모두 포함하는 조성물이 미나리, 갈근 또는 강황을 포함하는 각각의 조성물에 비해 ADH(Alocohol dehydrogenase) 활성을 촉진시켜 알코올을 빠르게 분해하므로 숙취해소에 효과가 있다는 것을 확인하고 본 발명을 완성하였다.Therefore, the present inventors have studied the composition for hangover relief, and as a result, the composition containing all of the buttercups, brown roots and turmeric promotes the alocohol dehydrogenase (ADH) activity compared to the respective compositions containing the buttercups, brown roots or turmeric. It was confirmed that it is effective in relieving hangover because it is rapidly decomposed and completed the present invention.
따라서 본 발명이 해결하고자 하는 과제는 미나리, 갈근 및 강황을 혼합하고 추출하여 알코올을 빠르게 분해하여 숙취해소능이 우수한 숙취해소용 조성물 및 건강기능식품을 제공하는데 있다.Therefore, the problem to be solved by the present invention is to provide a hangover relieving composition and health functional food with excellent hangover ability to break down alcohol by mixing and extracting parsley, brown root and turmeric.
상기 과제를 해결하려는 본 발명에 따른 숙취해소용 조성물은 미나리 1~3 중량부, 갈근 1~3 중량부 및 강황 1~3 중량부의 물, 에탄올 또는 에탄올 수용액 추출물을 포함한다.Hangover composition according to the present invention to solve the above problems comprises 1 to 3 parts by weight of parsley, 1 to 3 parts by weight and 1 to 3 parts by weight of turmeric water, ethanol or ethanol aqueous solution extract.
상기 미나리, 갈근 및 강황 추출시 사용되는 물, 에탄올 또는 에탄올 수용액은 미나리, 갈근 및 강황 사용량의 1~10배(v/w)일 수 있으며, 바람직하게는 5~10배(v/w)이다.The water, ethanol or ethanol aqueous solution used in the extraction of buttercup, brown root and turmeric may be 1 to 10 times (v / w) of the amount of buttercup, brown and turmeric, preferably 5 to 10 times (v / w). .
상기 숙취해소용 조성물은,The hangover composition,
미나리 1~3 중량부, 갈근 1~3 중량부 및 강황 1~3 중량부를 물, 에탄올 또는 에탄올 수용액으로 90~100℃에서 1~5시간 가열 추출하는 단계(1공정); 1 to 3 parts by weight of buttercup, 1 to 3 parts by weight of brown root and 1 to 3 parts by weight of turmeric with water, ethanol or an aqueous solution of ethanol at 90-100 ° C. for 1-5 hours (1 step);
상기 1공정에서 가열 추출된 추출물을 여과하는 단계(2공정);Filtering the extract extracted by heating in the first step (step 2);
상기 2공정에서 여과된 추출물을 감압농축하는 단계(3공정); 및Concentrating the extract filtered in the second step under reduced pressure (3 steps); And
상기 3공정에서 감압농축된 추출물을 건조하는 단계(4공정);Drying the extract concentrated under reduced pressure in step 3 (step 4);
를 포함한다.It includes.
상기 가열 추출물을 여과하는 2공정은 한외여과기를 사용하여 여과하는 단계를 포함할 수 있으며, 이외에 당분야에서 통상적으로 사용되는 여과법으로 여과할 수 있다.The two steps of filtering the heated extract may include filtering using an ultrafilter, and may be filtered by a filtration method commonly used in the art.
상기 여과된 추출물을 감압농축하는 3공정은 감압농축기를 사용하여 농축하는 단계를 포함할 수 있으며, 이외에 당분야에서 통상적으로 사용되는 농축법으로 농축할 수 있다.The three steps of concentrating the filtered extract under reduced pressure may include concentrating using a reduced pressure concentrator, and may be concentrated by a concentration method commonly used in the art.
상기 감압농축된 추출물을 건조하는 4공정은 동결건조기를 사용하여 건조하는 단계를 포함할 수 있으며, 이외에 당분야에서 통상적으로 사용되는 건조법으로 건조할 수 있다.The four steps of drying the concentrated extract under reduced pressure may include a step of drying using a lyophilizer, and may be dried by a drying method commonly used in the art.
상기 미나리, 갈근 및 강황의 물, 에탄올 또는 에탄올 수용액 추출물은 n-헥산, 메틸렌클로라이드, 아세톤, 에틸아세테이트 및 n-부탄올로 이루어진 군 중에서 선택된 1종 이상의 용매를 사용하여 추가적으로 분획할 수 있다. 상기 추출물 또는 추출물에 추가적인 용매를 사용하여 분획한 분획물의 제조온도는 20 내지 50℃일 수 있으나, 이에 제한되는 것은 아니다. 추출시간은 특별히 제한되는 것은 아니나, 10분 내지 1일 이내에 추출하는 것이 바람직하며, 추출용 기기로는 통상의 추출기기, 초음파분쇄추출기 또는 분획기를 이용할 수 있다. 이렇게 제조된 추출물은 열풍건조, 감압건조 또는/및 동결건조하여 용매를 제거할 수 있으나, 이에 제한되는 것은 아니며, 바람직하게는 감압건조하여 용매를 제거할 수 있다.The water, ethanol or turmeric extract of buttercup, brown root and turmeric may be further fractionated using one or more solvents selected from the group consisting of n-hexane, methylene chloride, acetone, ethyl acetate and n-butanol. The preparation temperature of the fraction fractionated by using an additional solvent to the extract or extract may be 20 to 50 ℃, but is not limited thereto. Extraction time is not particularly limited, but is preferably extracted within 10 minutes to 1 day, and the extraction device may be a conventional extraction device, ultrasonic grinding extractor or fractionator. The extract thus prepared may be removed by hot air drying, reduced pressure drying, and / or lyophilization, but is not limited thereto. Preferably, the extract may be dried under reduced pressure to remove the solvent.
본 발명의 미나리, 갈근 및 강황의 추출물을 포함하는 조성물은 통상의 방법에 따라 적절한 담체, 부형제 또는 희석제를 더 포함할 수 있다. 본 발명의 조성물에 포함될 수 있는 담체, 부형제 및 희석제로는 락토즈, 덱스트로즈, 수크로스, 솔비톨, 만니톨, 자일리톨, 에리스리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로즈, 메틸 셀룰로즈, 미정질 셀룰로스, 폴리비닐 피롤리돈, 물, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유를 들 수 있다. 본 발명에 따른 추출물을 포함하는 조성물은, 각각 통상의 방법에 따라 산제, 과립제, 정제, 캡슐제, 현탁액, 에멀젼, 시럽, 에어로졸 등의 경구형 제형, 외용제, 좌제 또는 멸균 주사용액의 형태로 제형화하여 사용될 수 있다. 상세하게는, 제제화 할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제될 수 있다. 경구투여를 위한 고형제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형제제는 상기 추출물에 적어도 하나 이상의 부형제 예를 들면, 전분, 탄산칼슘, 수크로스, 락토오스, 젤라틴 등을 섞어 조제될 수 있다. 또한, 단순한 부형제 이외에 마그네슘 스테아레이트, 탈크 같은 윤활제들도 사용될 수 있다. 경구를 위한 액상 제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데, 흔히 사용되는 단순 희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. 비경구 투여를 위한 제제에는 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조 제제 및 좌제가 포함된다. 비수성용제, 현탁제로는 프로필렌글리콜, 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔(witepsol), 마크로골, 트윈(tween)61, 카카오지, 라우린지, 글리세로제라틴 등이 사용될 수 있다.Compositions comprising extracts of buttercups, brown roots and turmeric of the present invention may further comprise suitable carriers, excipients or diluents according to conventional methods. Examples of carriers, excipients and diluents that can be included in the composition of the present invention include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber, alginate, gelatin, calcium phosphate, calcium silicate, Cellulose, methylcellulose, microcrystalline cellulose, polyvinylpyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil. Compositions comprising extracts according to the invention are each formulated in the form of powders, granules, tablets, capsules, suspensions, emulsions, syrups, aerosols and the like, oral preparations, suppositories or sterile injectable solutions according to conventional methods. Can be used. In detail, when formulated, it may be prepared using diluents or excipients such as fillers, extenders, binders, wetting agents, disintegrating agents, surfactants, etc. which are commonly used. Solid preparations for oral administration include tablets, pills, powders, granules, capsules, and the like, and the solid preparations include at least one excipient such as starch, calcium carbonate, sucrose, lactose, gelatin, and the like. Can be prepared by mixing. In addition to simple excipients, lubricants such as magnesium stearate and talc may also be used. Liquid preparations for oral use include suspensions, solvents, emulsions, and syrups.In addition to the commonly used simple diluents, water and liquid paraffin, various excipients such as wetting agents, sweeteners, fragrances, and preservatives may be included. have. Formulations for parenteral administration include sterilized aqueous solutions, non-aqueous solutions, suspensions, emulsions, freeze-dried preparations and suppositories. Examples of the suspending agent include propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate, and the like. As the base of the suppository, witepsol, macrogol, tween 61, cacao butter, laurin butter, glycerogelatin and the like can be used.
본 발명의 미나리, 갈근 및 강황 추출물을 포함하는 조성물은 숙취해소를 위한 식품 및 음료 등에 다양하게 이용될 수 있다. 본 발명의 추출물을 첨가할 수 있는 식품으로는, 각종 식품류, 예를 들어, 음료, 껌, 차, 비타민 복합제, 건강보조 식품류 등이 있으며, 환제, 분말, 과립, 침제, 정제, 캡슐 또는 음료인 형태로 사용할 수 있다. 이때, 식품 또는 음료 중의 상기 추출물의 양은, 일반적으로 본 발명의 건강식품 조성물의 경우 전체 식품 중량의 0.01 내지 15 중량%로 가할 수 있으며, 건강 음료 조성물의 경우 100㎖를 기준으로 0.02 내지 10g, 바람직하게는 0.3 내지 1g의 비율로 가할 수 있다. 본 발명의 건강 음료 조성물은 지시된 비율로 필수 성분으로서 상기 추출물을 함유하는 외에는 액체성분에는 특별한 제한점은 없으며 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. The composition comprising the buttercups, brown root and turmeric extract of the present invention can be used in a variety of food and beverages for hangover relief. Foods to which the extract of the present invention may be added include various foods, for example, beverages, gums, teas, vitamin complexes, dietary supplements, and the like, which are pills, powders, granules, tablets, tablets, capsules or beverages. Available in form. At this time, the amount of the extract in the food or beverage, in general, may be added to 0.01 to 15% by weight of the total food weight in the case of the health food composition of the present invention, 0.02 to 10g, based on 100ml for the health drink composition, preferably It may be added at a ratio of 0.3 to 1g. The health beverage composition of the present invention has no particular limitation on the liquid component except for containing the extract as an essential ingredient in the indicated ratio, and may contain various flavors or natural carbohydrates as additional ingredients, such as ordinary drinks.
상술한 천연 탄수화물의 예로는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토스, 슈크로스 등; 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린; 등과 같은 통상적인 당 및 자일리톨, 소르비톨, 에리트리톨 등의 당알코올이다. 상술한 것 이외의 향미제로서 천연 향미제(타우마틴, 스테비아 추출물 등) 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100㎖당 일반적으로 약 1 내지 20g, 바람직하게는 약 5 내지 12g이다. 상기 외에 본 발명의 조성물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다.Examples of the above-mentioned natural carbohydrates include monosaccharides such as glucose, fructose and the like; Disaccharides such as maltose, sucrose and the like; Polysaccharides such as dextrin, cyclodextrin; Conventional sugars such as and the like and sugar alcohols such as xylitol, sorbitol, and erythritol. As flavoring agents other than those described above, natural flavoring agents (tauumatin, stevia extract, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be advantageously used. The proportion of said natural carbohydrates is generally about 1 to 20 g, preferably about 5 to 12 g per 100 ml of the composition of the present invention. In addition to the above, the composition of the present invention includes various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, coloring and neutralizing agents (such as cheese and chocolate), pectic acid and salts thereof, alginic acid and its Salts, organic acids, protective colloidal thickeners, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated beverages, and the like.
그밖에 본 발명의 조성물들은 천연 과일 쥬스 및 과일 쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 이러한 첨가제의 비율은 그렇게 중요하진 않지만 본 발명의 조성물 100 중량부 당 0 내지 약 20 중량부의 범위에서 선택되는 것이 일반적이다.The compositions of the present invention may also contain pulp for the production of natural fruit juices and fruit juice beverages and vegetable beverages. These components can be used independently or in combination. The proportion of such additives is not so critical, but is generally selected in the range of 0 to about 20 parts by weight per 100 parts by weight of the composition of the present invention.
본 발명의 미나리, 갈근 및 강황 추출물을 포함하는 조성물은 알코올 대사에 관련된 간효소인 ADH의 활성을 촉진시키는 효능이 있어 알코올 섭취를 통해 나타나는 부작용인 갈증, 두통, 전신권태, 피로감, 기억상실 및 구토 등의 숙취현상을 개선하는 효과를 볼 수 있다.The composition comprising the extract of Buttercup, Carrot and Curcuma of the present invention is effective in promoting the activity of ADH, a liver enzyme related to alcohol metabolism, which is a side effect of alcohol consumption, thirst, headache, general boredom, fatigue, memory loss and vomiting. The effect of improving the hangover phenomenon, etc. can be seen.
또한, 미나리, 갈근 및 강황 추출물은 알코올 대사에 관련된 간효소인 ADH를 활성화시켜 에탄올을 최종 대사산물인 아세트산으로 빠르게 분해시키므로 알코올 섭취로 인한 간의 손상을 줄일 수 있으며, 그 외에 위염, 췌장염, 고혈압, 중풍 및 식도염 등의 알코올 섭취로 인해 나타나는 질환들을 개선하는 효과를 볼 수 있다.In addition, parsley, brown root and turmeric extracts can rapidly decompose ethanol into acetic acid, the final metabolite by activating ADH, a liver enzyme involved in alcohol metabolism, thereby reducing liver damage from alcohol intake. In addition, gastritis, pancreatitis, high blood pressure, It can help to improve diseases caused by alcohol consumption such as stroke and esophagitis.
도 1은 본 발명에 따른 숙취해소용 조성물의 제조공정을 순차적으로 나타내는 공정도이다.
도 2는 숙취해소용 조성물의 혈중 알코올 농도 저하 효과를 나타낸 것이다.1 is a process chart sequentially showing the manufacturing process of the hangover relief composition according to the present invention.
Figure 2 shows the effect of lowering the blood alcohol concentration of the hangover relief composition.
이하, 본 발명의 바람직한 실시 예를 설명하기로 한다. 그러나 본 발명은 여기서 설명되어지는 실시 예에 한정되지 않고 다른 형태로 구체화될 수도 있다.Hereinafter, preferred embodiments of the present invention will be described. However, the present invention is not limited to the embodiments described herein and may be embodied in other forms.
<실시예 1> 숙취해소용 조성물 제조Example 1 Preparation of Hangover Relief Composition
미나리 100g, 갈근 100g 및 강황 100g을 정제수 1.5ℓ에 넣고 100℃에서 3시간 가열 추출하고 한외여과기를 사용하여 여과하였다. 여액을 감압농축기로 농축한 후, 동결건조기로 건조하여 숙취해소용 조성물을 제조하였다.100 g of buttercup, 100 g of brown root and 100 g of turmeric were added to 1.5 L of purified water and extracted by heating at 100 ° C. for 3 hours, followed by filtration using an ultrafilter. The filtrate was concentrated in a vacuum condenser, and then dried in a lyophilizer to prepare a hangover composition.
<실시예 2> 숙취해소용 조성물 제조Example 2 Preparation for Hangover Relief
상기 실시예 1과 동일한 방법으로 하되, 정제수 대신 에탄올 1.5ℓ로 숙취해소용 조성물을 제조하였다. In the same manner as in Example 1, but instead of purified water to prepare a hangover composition for 1.5L ethanol.
<실시예 3~8> 숙취해소용 조성물 제조<Examples 3-8> Preparation for Hangover Relief
상기 실시예 1과 동일한 방법으로 하되, 하기 표 1과 같은 조건으로, 미나리, 갈근 및 강황의 총 중량의 5배 용량의 정제수를 넣어 실시예 3~8의 숙취해소용 조성물을 제조하였다.In the same manner as in Example 1, but under the same conditions as in Table 1, 5 times the volume of purified water of parsley, brown root and turmeric was added to prepare a hangover composition of Examples 3-8.
<비교예 1~9> 비교 조성물 제조<Comparative Examples 1-9> Preparation of Comparative Composition
상기 실시예 1과 동일한 방법으로 하되, 하기 표 1과 같은 조건으로, 미나리, 갈근 및 강황의 총 중량의 5배 용량의 정제수를 넣어 비교예 1~9의 조성물을 제조하였다.In the same manner as in Example 1, but under the same conditions as in Table 1, the composition of Comparative Examples 1 to 9 by preparing purified water having a capacity of 5 times the total weight of buttercups, roots and turmeric.
<실험예 1> 숙취해소용 조성물의 ADH 활성 측정Experimental Example 1 Measurement of ADH Activity of Hangover Relief Composition
상기 실시예 1~8과 비교예 1~9에서 제조된 조성물의 ADH 활성 측정 실험을 하였다.ADH activity measurement experiments of the compositions prepared in Examples 1 to 8 and Comparative Examples 1 to 9 were performed.
알코올 및 아세트알데하이드 분석 kit를 사용하여 상기 실시예 1~8과 비교예 1~9의 조성물을 각각 증류수에 1 ㎎/㎖ 농도로 녹여 사용하였으며 처리군과 대조군(음용수)의 반응 생성물인 NADH 생성량을 자외선분광광도기(UV spectrophotometer)를 사용하여 340nm에서 흡광도를 측정하였다. 각각의 조성물의 활성은 in vitro assay system을 이용하여 측정하여 대조구에 대한 상대율로 표시하였다. 실험결과는 하기 표 2에 나타내었다.Using the alcohol and acetaldehyde analysis kit, the compositions of Examples 1-8 and Comparative Examples 1-9 were dissolved in distilled water at a concentration of 1 mg / ml, respectively, and the amount of NADH produced as a reaction product of the treated group and the control group (drinking water) was used. Absorbance was measured at 340 nm using an UV spectrophotometer. The activity of each composition was measured using an in vitro assay system and expressed as a relative rate relative to the control. The experimental results are shown in Table 2 below.
상기 표 2와 같이, 미나리, 갈근 및 강황으로 제조된 실시예 1~8의 조성물은 미나리만 함유되어 있는 비교예 4, 갈근만 함유되어 있는 비교예 5 및 강황만 함유되어 있는 비교예 6의 조성물보다 높은 ADH 활성을 나타내었다.As shown in Table 2, the compositions of Examples 1 to 8 prepared from buttercups, brown roots and turmeric are Comparative Example 4 containing only buttercups, Comparative Example 5 containing only brown roots and the composition of Comparative Example 6 containing only turmeric It showed higher ADH activity.
따라서, 본 발명에 따른 실시예 1~8에서 미나리 1~3 중량부, 갈근 1~3 중량부 및 강황 1~3 중량부를 혼합하여 제조된 조성물은 이들 생약 각각의 조성물에 비해 상승적인 ADH 활성 증가 효과가 우수한 것으로 확인되었다.Therefore, the compositions prepared by mixing 1-3 parts by weight of parsley, 1-3 parts by weight and 1-3 parts by weight of turmeric in Examples 1 to 8 according to the present invention increase synergistic ADH activity compared to each of these herbal compositions. The effect was confirmed to be excellent.
<실험예 2> 숙취해소용 조성물의 혈중 알코올 농도 저하 측정Experimental Example 2 Determination of Blood Alcohol Concentration of Hangover Relief Composition
상기 실시예 1과 비교예 4~6에서 제조된 조성물의 혈중 알코올 농도 저하 측정 실험을 하였다.Blood alcohol concentration decrease measurement experiments of the compositions prepared in Example 1 and Comparative Examples 4-6.
실험에 사용한 쥐는 Sprague-Dawley계 수컷 쥐(6주령, 체중 180~200g)이며, 7일간 적응 사육한 후 사용하였으며, 사육온도는 22±2℃, 조명시간은 12시간(8:00~20:00)을 유지하였고, 고형사료(수퍼피드)와 물을 실험 12시간 전까지 자유급여 하였다.The rats used in the experiment were Sprague-Dawley male rats (6 weeks old,
상기 실시예 1과 비교예 4~6에서 제조된 조성물을 각각 1.5g/㎏의 양으로 음용수에 녹여 실험 대상 쥐에 1㎖씩 경구투여하였으며, 대조군에는 동량의 음용수를, 양성대조군에는 동량의 여명808(주식회사 그래미)을 실험 대상 쥐에 경구투여 하였다. 경구투여 30분 후, 40% 에탄올 수용액 1㎖를 경구투여하였다. 40% 에탄올 수용액 투여 전과 투여 후 1, 2 및 4시간에 쇄골하정맥으로부터 0.2㎖의 혈액을 채취하여 혈청을 얻었으며, EnzyChrom Ethanol Assay Kit를 이용하여 반응시킨 후 570㎚에서 흡광도를 측정하였다. 실험결과는 하기 표 3에 나타내었다.The compositions prepared in Example 1 and Comparative Examples 4 to 6 were dissolved in drinking water in an amount of 1.5 g / kg, respectively, and orally administered to 1 ml of the test subject rats. 808 (Grammy, Inc.) was orally administered to the test subject rats. 30 minutes after oral administration, 1 ml of 40% aqueous ethanol solution was orally administered. Serum was obtained by taking 0.2 ml of blood from the subclavian vein before and after administration of 40% aqueous ethanol solution and at 1, 2 and 4 hours. The absorbance was measured at 570 nm after reacting with EnzyChrom Ethanol Assay Kit. The experimental results are shown in Table 3 below.
상기 표 3과 같이, 미나리, 갈근 및 강황으로 제조된 실시예 1의 조성물은 미나리만 함유되어 있는 비교예 4, 갈근만 함유되어 있는 비교예 5 및 강황만 함유되어 있는 비교예 6의 조성물보다 혈중 알코올 농도가 시간이 지남에 따라 현저하게 감소한 것으로 나타났으며, 양성대조군(여명808)보다도 혈중 알코올 농도 감소 효과가 높은 것으로 나타났다.(도 2 참조)As shown in Table 3, the composition of Example 1 prepared with buttercups, brown roots and turmeric is less than the composition of Comparative Example 4 containing only buttercups, Comparative Example 5 containing only roots and Comparative Example 6 containing only turmeric The alcohol concentration was significantly decreased over time, and the effect of reducing the alcohol concentration in the blood was higher than that of the positive control group (dawn 808).
따라서, 본 발명에 따른 실시예 1에서 미나리 1~3 중량부, 갈근 1~3 중량부 및 강황 1~3 중량부를 혼합하여 제조된 조성물은 혈중 알코올 농도 저하효과가 우수한 것으로 확인되었다.Therefore, in Example 1 according to the present invention, the composition prepared by mixing 1-3 parts by weight of parsley, 1-3 parts by weight and 1-3 parts by weight of turmeric was found to have an excellent effect of lowering blood alcohol concentration.
<실험예 3> 숙취해소용 조성물의 숙취해소 효과 평가Experimental Example 3 Evaluation of Hangover Relief Effect of Hangover Relief Composition
상기 실시예 1과 비교예 4~6에서 제조된 조성물의 숙취해소 효과 평가를 하였다.The hangover relief effect of the compositions prepared in Example 1 and Comparative Examples 4 to 6 was evaluated.
20대 성인남자 80명을 대상으로 하였으며, 실험 대상자(80명)에게 시판 소주(알코올 20%) 300㎖을 섭취하게 하고 30분 후에 상기 실시예 1과 비교예 4~6에서 제조된 조성물을 0.15g/㎏의 양으로 음용수에 녹이고 각각 20명씩 총 4그룹으로 나누어 75㎖씩 섭취하게 하였다. 숙취해소 효과는 7점 척도법으로 다음날 음주에 따라 나타나는 숙취현상인 두통 및 갈증의 정도에 따라 비교 평가를 하였다.80 adult men in their 20s were included, and the test subjects (80 persons) ingested 300 ml of commercial soju (20% alcohol), and after 30 minutes, the composition prepared in Examples 1 and Comparative Examples 4-6 was 0.15. It was dissolved in drinking water in the amount of g / ㎏ and divided into 4 groups of 20 people each was ingested 75ml. The hangover elimination effect was evaluated by the 7-point scale according to the degree of headache and thirst, which is a hangover phenomenon caused by drinking the next day.
<평가기준><Evaluation Criteria>
두통 갈증Headache thirst
1 : 두통이 매우 심함 1 : 갈증이 매우 심함1: very severe headache 1: very thirsty
3 : 두통이 약간 있음 3 : 갈증이 약간 있음3: a little headache 3: little thirst
5 : 두통이 거의 없음 5 : 갈증이 거의 없음5: almost no headache 5: almost no thirst
7 : 두통이 없음 7 : 갈증이 없음7: no headache 7: no thirst
상기 표 4와 같이, 미나리, 갈근 및 강황으로 제조된 실시예 1의 조성물은 미나리만 함유되어 있는 비교예 4, 갈근만 함유되어 있는 비교예 5 및 강황만 함유되어 있는 비교예 6의 조성물보다 음주시 나타나는 숙취현상인 두통 및 갈증 해소 효과가 높은 것으로 나타났다.As shown in Table 4, the composition of Example 1 prepared with buttercups, brown roots and turmeric is less drunk than the composition of Comparative Example 4 containing only buttercups, Comparative Example 5 containing only roots and Comparative Example 6 containing only turmeric It has been shown to have high headache and thirst quenching effects.
따라서, 본 발명에 따른 실시예 1에서 미나리 1~3 중량부, 갈근 1~3 중량부 및 강황 1~3 중량부를 혼합하여 제조된 조성물은 음주시 나타나는 숙취현상 개선 효과가 우수한 것으로 확인되었다.Therefore, the composition prepared by mixing 1 to 3 parts by weight of parsley, 1 to 3 parts by weight and 1 to 3 parts by weight of turmeric in Example 1 according to the present invention was found to be excellent in the hangover phenomenon improvement effect when drinking.
<실험예 4> 렛트에 대한 급성경구투여 독성실험Experimental Example 4 Acute Oral Administration of Rats
6주령의 특정병원부재(SPF) SD계 랫트를 사용하여 급성독성실험을 다음과 같이 실시하였다. 군당 2 마리씩의 동물에 본 발명의 실시예 1의 미나리, 갈근 및 강황 조성물을 용해시켜 1 g/㎏/㎖의 용량으로 단회 경구 투여하였다. 조성물을 투여한 후 동물의 폐사 여부, 임상증상, 체중변화를 관찰하고 혈액학적 검사와 혈액생화학적 검사를 실시하였으며, 부검하여 육안으로 복강장기와 흉강장기의 이상여부를 관찰하였다. 그 결과, 시험물질을 투여한 모든 동물에서 특기할 만한 임상증상이나 폐사된 동물은 없었으며, 체중변화, 혈액검사, 혈액생화학 검사, 부검소견 등에서도 독성변화는 관찰되지 않았다. 따라서 본 발명에 따른 조성물은 모든 랫트에서 5,000 ㎎/㎏까지 독성변화를 나타내지 않았으며 경구 투여 최소 치사량(LD50값)은 5,000 ㎎/㎏ 이상인 안전한 물질로 판단되었다.Acute toxicity test was performed using 6-week-old SPF SD rats as follows. Two animals per group were dissolved in the buttercups, roots and turmeric compositions of Example 1 of the present invention and administered orally at a dose of 1 g / kg / ml. After administration of the composition, the mortality, clinical symptoms, and weight changes of the animals were observed. Hematological and hematological examinations were performed. The necropsy was performed to visually observe the abdominal and thoracic organ abnormalities. As a result, no significant clinical symptoms or dead animals were noted in all animals treated with the test substance, and no toxic changes were observed in weight changes, blood tests, blood biochemical tests, and autopsy findings. Therefore, the composition according to the present invention did not show a change in toxicity in all rats up to 5,000 mg / kg and the minimum lethal dose (LD 50 value) was determined to be a safe substance of more than 5,000 mg / kg.
<제조예 1> 산제의 제조예Production Example 1 Production Example of Powder
실시예 1의 숙취해소용 조성물 30㎎30 mg hangover relief composition of Example 1
유당 100㎎Lactose 100mg
탈크 10㎎Talc 10mg
상기의 성분들을 혼합하고 기밀포에 충진하여 산제를 제조한다.The above ingredients are mixed and filled in an airtight cloth to prepare a powder.
<제조예 2> 정제의 제조예Preparation Example 2 Preparation of Tablet
실시예 1의 숙취해소용 조성물 100㎎100 mg of hangover composition of Example 1
옥수수전분 100㎎Corn Starch 100mg
유당 100㎎Lactose 100mg
스테아린산 마그네슘 2㎎2 mg magnesium stearate
상기의 성분들을 혼합한 후 통상의 정제의 제조방법에 따라서 타정하여 정제를 제조한다.
After mixing the above components, tablets are prepared by tableting according to a conventional method for preparing tablets.
<제조예 3> 액제의 제조예Production Example 3 Production Example of Liquid
실시예 1의 숙취해소용 조성물 300㎎300 mg of hangover composition of Example 1
이성화당 10g10 g of isomerized sugar
만니톨 5gMannitol 5g
정제수 적량Purified water
통상의 액제의 제조방법에 따라 정제수에 각각의 성분을 가하여 용해시키고 레몬향을 적량 가한 다음 상기의 성분을 혼합한 다음 정제수를 가하여 전체 100㎖로 조절한 후 갈색병에 충진하여 멸균시켜 액제를 제조한다.According to the conventional method of preparing a liquid solution, each component is added to the purified water to dissolve it, and lemon flavor is added thereto, then the above ingredients are mixed, adjusted to 100 ml by adding purified water, and then filled into a brown bottle and sterilized to prepare a liquid solution. do.
<제조예 4> 건강식품의 제조예Production Example 4 Production Example of Health Food
실시예 1의 숙취해소용 조성물 1000㎎1000 mg hangover relief composition of Example 1
비타민 A 아세테이트 70㎍70 μg of vitamin A acetate
비타민 E 1.0㎎Vitamin E 1.0mg
비타민 B1 0.13㎎Vitamin B1 0.13mg
비타민 B2 0.15㎎Vitamin B2 0.15mg
비타민 B6 0.5㎎Vitamin B6 0.5mg
비타민 B12 0.2㎍0.2 µg of vitamin B12
비타민 C 10㎎Vitamin C 10mg
비오틴 10㎍10 μg biotin
니코틴산아미드 1.7㎎Nicotinamide 1.7mg
엽산 50㎍Folate 50 ㎍
판토텐산 칼슘 0.5㎎Calcium Pantothenate 0.5mg
무기질 혼합물 적량Mineral mixture
황산제1철 1.75㎎Ferrous Sulfate 1.75mg
산화아연 0.82㎎Zinc Oxide 0.82mg
탄산마그네슘 25.3㎎Magnesium Carbonate 25.3mg
제1인산칼륨 15㎎15 mg potassium monophosphate
제2인산칼슘 55㎎Dicalcium Phosphate 55mg
구연산칼륨 90㎎Potassium Citrate 90mg
탄산칼슘 100㎎Calcium Carbonate 100mg
염화마그네슘 24.8㎎Magnesium chloride 24.8mg
상기의 비타민 및 미네랄 혼합물의 조성비는 비교적 건강식품에 적합한 성분을 바람직한 제제예로 혼합 조성하였지만, 그 배합비를 임의로 변형 실시하여도 무방하며, 통상의 건강식품 제조방법에 따라 상기의 성분을 혼합한 다음, 과립을 제조하고, 통상의 방법에 따라 건강식품 조성물 제조에 사용할 수 있다.The composition ratio of the above-mentioned vitamin and mineral mixtures is composed of relatively suitable ingredients for health foods as a preferred formulation, but the formulation ratio may be arbitrarily modified, and the above ingredients may be mixed according to a general health food manufacturing method. The granules may be prepared and used for preparing a health food composition according to a conventional method.
<제제예 5> 건강 음료의 제조Preparation Example 5 Preparation of Healthy Drinks
실시예 1의 숙취해소용 조성물 1000㎎1000 mg hangover relief composition of Example 1
구연산 100㎎Citric Acid 100mg
올리고당 100gOligosaccharide 100g
매실농축액 2gPlum concentrate 2g
타우린 1g1 g of taurine
정제수를 가하여 전체 900㎖Add 900 ml of purified water
통상의 건강음료 제조방법에 따라 상기의 성분을 혼합한 다음, 약 1시간동안 85℃에서 교반 가열한 후, 만들어진 용액을 여과하여 멸균된 2ℓ용기에 취득하여 밀봉 멸균한 뒤 냉장 보관한 다음 본 발명의 건강음료 조성물 제조에 사용한다. After mixing the above components according to a conventional healthy beverage production method, and then stirred and heated at 85 ℃ for about 1 hour, the resulting solution is filtered and obtained by sterilization in a sterilized 2 L container, sealed sterilized and then stored in the present invention For the preparation of healthy beverage compositions.
상기 조성비는 비교적 기호음료에 적합한 성분을 바람직한 제제예로 혼합 조성하였지만 수요계층이나, 수요국가, 사용 용도 등 지역적, 민족적 기호도에 따라서 그 배합비를 임의로 변형 실시하여도 무방하다.Although the composition ratio is a composition suitable for a preferred beverage in a preferred formulation example, the compounding ratio may be arbitrarily modified according to regional and ethnic preferences such as demand hierarchy, demand country, and use purpose.
Claims (3)
상기 1공정에서 가열 추출된 추출물을 여과하는 단계(2공정);
상기 2공정에서 여과된 추출물을 감압농축 하는 단계(3공정); 및
상기 3공정에서 감압농축된 추출물을 건조하는 단계(4공정);
를 포함하는 것을 특징으로 하는 숙취해소용 건강기능식품의 제조방법.1 to 3 parts by weight of buttercups, 1 to 3 parts by weight of roots and 1 to 3 parts by weight of turmeric, at 90 to 100 ° C with 5-10 times (v / w) water, ethanol or ethanol aqueous solution of buttercups, roots and turmeric Heating extraction for 5 hours (step 1);
Filtering the extract extracted by heating in the first step (step 2);
Concentrating the extract extracted in the second step under reduced pressure (3 steps); And
Drying the extract concentrated under reduced pressure in step 3 (step 4);
Method for producing a health functional food for hangover relief comprising a.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100130184A KR101034986B1 (en) | 2010-12-17 | 2010-12-17 | Composition comprising the mixed herbal extract for relieving hangover |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100130184A KR101034986B1 (en) | 2010-12-17 | 2010-12-17 | Composition comprising the mixed herbal extract for relieving hangover |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101034986B1 true KR101034986B1 (en) | 2011-05-17 |
Family
ID=44366123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100130184A KR101034986B1 (en) | 2010-12-17 | 2010-12-17 | Composition comprising the mixed herbal extract for relieving hangover |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101034986B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101249559B1 (en) * | 2011-10-18 | 2013-04-01 | 우석대학교 산학협력단 | Preparation method of concentrated powder included scutellaria radix and alnus japonica |
CN105687495A (en) * | 2014-11-28 | 2016-06-22 | 广西大学 | Raisin tree seed instant granules dispelling effects of alcohol and protecting the liver |
KR20210116929A (en) * | 2020-03-18 | 2021-09-28 | 주식회사 케이에스하니 | Method for manufacturing hangover recovery agent and hangover recovery agent manufactured by the same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080035853A (en) * | 2006-10-20 | 2008-04-24 | 주식회사 경인제약 | A composition having protective function from alcoholic hangover comprising dropwort extract as active ingredient and functional health food using the same |
KR20100026487A (en) * | 2008-08-29 | 2010-03-10 | 충청대학 산학협력단 | Drink for mitigating hangover using jujube and manufacturing method thereof |
-
2010
- 2010-12-17 KR KR1020100130184A patent/KR101034986B1/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080035853A (en) * | 2006-10-20 | 2008-04-24 | 주식회사 경인제약 | A composition having protective function from alcoholic hangover comprising dropwort extract as active ingredient and functional health food using the same |
KR20100026487A (en) * | 2008-08-29 | 2010-03-10 | 충청대학 산학협력단 | Drink for mitigating hangover using jujube and manufacturing method thereof |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101249559B1 (en) * | 2011-10-18 | 2013-04-01 | 우석대학교 산학협력단 | Preparation method of concentrated powder included scutellaria radix and alnus japonica |
CN105687495A (en) * | 2014-11-28 | 2016-06-22 | 广西大学 | Raisin tree seed instant granules dispelling effects of alcohol and protecting the liver |
KR20210116929A (en) * | 2020-03-18 | 2021-09-28 | 주식회사 케이에스하니 | Method for manufacturing hangover recovery agent and hangover recovery agent manufactured by the same |
KR102557388B1 (en) * | 2020-03-18 | 2023-07-20 | 주식회사 케이에스하니 | Method for manufacturing hangover recovery agent and hangover recovery agent manufactured by the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101433188B1 (en) | Composition For Relieving Alcohol-induced Hangover Comprising Starch, Amino Acids, Active Complex Vitamin And Oriental Herb Medicine materials AND, The Manufacturing Method Thereof | |
TWI500391B (en) | Composition for reliving and preventing hangover and beverage comprising composition | |
KR101301094B1 (en) | Composition for relieving hangover or improving liver function | |
KR101346244B1 (en) | Composition for preventing or relieving alcohol-induced hangover comprising medicinal herbs | |
KR101164083B1 (en) | Composition comprising glehnia littoralis fr. schmidt et miquel extract for relieving hangover | |
KR101930483B1 (en) | Smilax china leaf fermented with Aspergillus species and Extract of the same | |
CN110897147A (en) | Dendrobium officinale alcohol-dispelling and liver-protecting composition and preparation method thereof | |
KR20160117034A (en) | Composition for improving sexual functionality having effects of increasing of the number of sperm and protection of environmental hormone and manufacturing method thereof | |
KR101930277B1 (en) | Composition for Preventing and Improving Hangover | |
KR100552398B1 (en) | An alcohol detoxification beverage comprising extract of horse bean | |
KR101253658B1 (en) | Manufacturing method of treated puffing and fermentation red ginseng concentrate | |
JP2013203683A (en) | Type iii collagen production promotor | |
KR101394358B1 (en) | Health composition relieving alcohol hangover | |
KR101034986B1 (en) | Composition comprising the mixed herbal extract for relieving hangover | |
KR100976241B1 (en) | Extract of sedum sarmentosum for alcohol oxidation and relieves hangover | |
KR101310648B1 (en) | Composition comprising leaves of peucedanum japonicum for relieving hangover or fermented liquor having leaves of peucedanum japonicum | |
KR102197395B1 (en) | The process of making healthcare composition for relieving and preventing alcoholic hangover comprising fermented Dendropanax morbifera extract and Capsosiphon fulvescens extracts | |
KR20210063657A (en) | A natural tea removing the effect of hangover contained the extract material in Hovenia dulcis and a cactus | |
KR101210748B1 (en) | Composition comprising the extract of Acanthopanax sessiliflorus and green tea for treating or alleviating hangover syndrome | |
KR101795261B1 (en) | Medicinal-Herb Composition Comprising Chinese matrimony vine for Treatmenting and Protecting the Insomniac and the Method of Making the Same | |
KR102433586B1 (en) | Food composition for relieving hangover and improving hepatic function | |
KR102127411B1 (en) | Composition comprising natural complex extract for protecting liver and relieving hangover | |
KR101482044B1 (en) | Food composition comprising fermented product of Pleuropterus multiflorus and ginger for alleviating or preventing degenerative brain disorder and method of producing the same | |
KR20170086198A (en) | Manufacturing method of diet solid tea including fermentation herb remedy and dietary fiber and the solid tea produced thereby | |
KR100642801B1 (en) | Anti-diabetic food composition comprising extracts from natural herbal materials and pear and process for preparing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |